MedTrace Logo

Small Doses of Dexmedetomidine for Emergence Agitation

NCT02169843 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-06-23

No results posted yet for this study

Summary

Dexmedetomidine Hydrochloride is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the activity of sympathetic nerve, and reduce the adverse effects of stress reaction in anesthesia recovery period.Literatures have been reported that Dex can reduce the rate of emergence agitation of children and adults,especially in elderly patients(\>64 years) after using sevoflurane anesthesia.

Conditions

  • Emergence Agitation

Interventions

DRUG

Sevoflurane

inhale Sevoflurane

DRUG

Dexmedetomidine

intravenous pumping Dexmedetomidine 0.2µg/kg/h

DRUG

Placebo(for Dexmedetomidine)

normal saline mimic Dexmedetomidine, intravenous pumping 0.05ml/kg/h

Sponsors & Collaborators

  • Tang-Du Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02169843 on ClinicalTrials.gov